High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$274M
$274,091,497
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KOD
P
Kodiak Sciences Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary BuyΔOwn +16.2%
2025-12-18
$60,000,008MEGAx2
|
||||||
| KOD |
Kodiak Sciences Inc.
|
Director
Discretionary BuyΔOwn +16.2%
|
2025-12-18 | $60,000,008MEGAx2 | P | Form 4 |
|
DNLI
P
Denali Therapeutics Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary Buy
2025-12-11
$39,977,138MEGAx2
|
||||||
| DNLI |
Denali Therapeutics Inc.
|
Director
Discretionary Buy
|
2025-12-11 | $39,977,138MEGAx2 | P | Form 4 |
|
KYMR
P
Kymera Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary BuyΔOwn +31.3%
2025-12-11
$172,499,918MEGAx2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +31.3%
|
2025-12-11 | $172,499,918MEGAx2 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-20
$261,846x4
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-20 | $261,846x4 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-12
$781,638x4
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-12 | $781,638x4 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-11
$348,193x4
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-11 | $348,193x4 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-10
$222,756x4
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-10 | $222,756x4 | P | Form 4 |